We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.99%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$124B
AUM Growth
-$818M
(-0.66%)
Cap. Flow
-$3.27B
Cap. Flow
% of AUM
-2.65%
Top 10 Holdings %
Top 10 Hldgs %
32.71%
Holding
4,253
New
85
Increased
832
Reduced
2,978
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$588M |
| 2 |
CRH
CRH
|
+$47.1M |
| 3 |
Carvana
CVNA
|
+$34.4M |
| 4 |
Q
Qnity Electronics Inc
Q
|
+$33.9M |
| 5 |
Pinterest
PINS
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$326M |
| 2 |
Apple
AAPL
|
+$286M |
| 3 |
Microsoft
MSFT
|
+$251M |
| 4 |
MRSH
Marsh
MRSH
|
+$174M |
| 5 |
Amazon
AMZN
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Financials | 13.22% |
| 3 | Consumer Discretionary | 10.75% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Syndax Pharmaceuticals
SNDX
$1.7B
| $2.5M | ﹤0.01% |
118,799
-12,870
| -10% | -$225K |
|
1727
Applied Optoelectronics
AAOI
$12.6B
| $2.48M | ﹤0.01% |
71,089
-5,969
| -8% | -$178K |
|
1728
AvePoint
AVPT
$2.89B
| $2.47M | ﹤0.01% |
178,073
-17,934
| -9% | -$248K |
|
1729
Certara
CERT
$1.23B
| $2.45M | ﹤0.01% |
278,136
-343
| -0.1% | -$3.53K |
|
1730
SolarEdge
SEDG
$2.01B
| $2.45M | ﹤0.01% |
84,900
+1,420
| +2% | +$49.5K |
|
1731
LGI Homes
LGIH
$1.39B
| $2.45M | ﹤0.01% |
56,918
-4,640
| -8% | -$218K |
|
1732
Shinhan Financial Group
SHG
$35.3B
| $2.44M | ﹤0.01% |
45,537
-6,425
| -12% | -$339K |
|
1733
Immunome
IMNM
$2.99B
| $2.44M | ﹤0.01% |
113,565
+5,485
| +5% | +$96.3K |
|
1734
Sabesp
SBS
$15.8B
| $2.44M | ﹤0.01% |
512,103
-58,868
| -10% | -$284K |
|
1735
Appian
APPN
$2.57B
| $2.43M | ﹤0.01% |
68,547
-8,804
| -11% | -$314K |
|
1736
Phibro Animal Health
PAHC
$1.4B
| $2.43M | ﹤0.01% |
64,912
-2,697
| -4% | -$110K |
|
1737
OneSpaWorld
OSW
$2.73B
| $2.42M | ﹤0.01% |
116,794
-17,949
| -13% | -$376K |
|
|
TRST
1738
Trustco Bank Corp NY
TRST
$977M
| $2.42M | ﹤0.01% |
58,567
-5,051
| -8% | -$201K |
|
1739
Helios Technologies
HLIO
$2.71B
| $2.42M | ﹤0.01% |
45,252
-7,138
| -14% | -$385K |
|
1740
CVR Energy
CVI
$3.57B
| $2.42M | ﹤0.01% |
94,962
-7,563
| -7% | -$257K |
|
1741
Southside Bancshares
SBSI
$983M
| $2.41M | ﹤0.01% |
79,425
-4,496
| -5% | -$132K |
|
1742
Wave Life Sciences
WVE
$1.04B
| $2.41M | ﹤0.01% |
141,895
-17,278
| -11% | -$176K |
|
1743
Hanmi Financial
HAFC
$964M
| $2.41M | ﹤0.01% |
89,121
+377
| +0.4% | +$10.1K |
|
1744
1st Source
SRCE
$2.14B
| $2.41M | ﹤0.01% |
38,496
-2,707
| -7% | -$167K |
|
|
TIC
1745
TIC Solutions Inc
TIC
$2.15B
| $2.4M | ﹤0.01% |
237,422
-9,338
| -4% | -$104K |
|
1746
AstraZeneca
AZN
$241B
| $2.4M | ﹤0.01% |
13,047
-341
| -3% | -$59.8K |
|
1747
Lionsgate Studios
LION
$3.57B
| $2.4M | ﹤0.01% |
262,582
-34,488
| -12% | -$245K |
|
1748
KB Financial Group
KB
$42.1B
| $2.4M | ﹤0.01% |
27,853
-4,396
| -14% | -$370K |
|
|
INVX
1749
Innovex International
INVX
$2.21B
| $2.39M | ﹤0.01% |
109,459
-7,153
| -6% | -$149K |
|
1750
TotalEnergies
TTE
$195B
| $2.39M | ﹤0.01% |
36,566
+8,196
| +29% | +$518K |
|
Similar funds
RhumbLine Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, RhumbLine Advisers held 4,253 positions worth $124B, down 0.66% from $125B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 3.6%. RhumbLine Advisers opened 85 new positions and exited 67, leaving the 4,253-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q4 2025 buy was Qnity Electronics Inc: 399,119 shares worth $32.6M.
- RhumbLine Advisers added most to iShares Russell 3000 ETF in Q4 2025, an estimated $588M increase.
- RhumbLine Advisers's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $326M.
- RhumbLine Advisers fully exited Kellanova in Q4 2025, selling an estimated $52.6M.
- RhumbLine Advisers's ten largest holdings make up 33% of its $124B portfolio in Q4 2025.
- RhumbLine Advisers opened 85 new positions and closed 67 in Q4 2025.
- RhumbLine Advisers's portfolio value fell 0.66% quarter-over-quarter to $124B.
Based on RhumbLine Advisers's 13F filing for Q4 2025, filed 13 Feb 2026.